Skip to main content

Table 2 Characteristics of the n = 1402 participants, by category of body mass index.

From: Apolipoprotein ε4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: a cross-sectional cohort study

 

BMI ≤ 25 kg/m2*

25 < BMI ≤ 30 kg/m2

BMI > 30 kg/m2

 

Characteristic

n = 407 (29.0%)

n = 565 (40.3%)

n = 430 (30.7%)

p-value

Age, mean (SD)*

56.2 (11.1)

57.1 (11.3)

55.8 (10.6)

0.57

Carrier ε4 allele, no. (%)*

112 (27.5)

162 (28.7)

123 (28.6)

0.73

Male, no. (%)

143 (35.1)

330 (58.4)

192 (44.7)

0.008

BMI, kg/m2, mean (SD)*

22.8 (1.7)

27.4 (1.4)

34.9 (4.6)

--

Current smoker, no. (%)

69 (17.0)

77 (13.6)

37 (8.6)

0.0003

≥ 2 alcoholic drinks daily, no. (%)

209 (51.4)

287 (50.8)

198 (46.1)

0.12

Monounsaturated fat intake, mean (SD)

21.8 (12.6)

24.0 (12.5)

25.0 (37.0)

0.0004

Polyunsaturated fat intake, mean (SD)

8.4 (4.4)

8.9 (4.7)

9.2 (5.1)

0.02

Exercise in minutes/day, mean (SD)

30.1 (33.8)

28.6 (35.3)

24.5 (37.0)

0.02

HDL, mg/dL, mean (SD)*

55.1 (17.5)

46.5 (14.2)

44.0 (12.4)

< 0.0001

LDL, mg/dL, mean (SD)*

129.7 (35.1)

131.5 (38.9)

128.2 (32.5)

0.53

Triglycerides, mg/dL, mean (SD)

134.0 (105.7)

179.5 (103.0)

186.6 (107.5)

< 0.0001

Diabetes mellitus, no. (%)

17 (4.2)

53 (9.4)

52 (12.1)

< 0.0001

Hypertension, no. (%)

103 (25.3)

202 (35.8)

175 (40.7)

< 0.0001

Coronary heart disease, no. (%)

57 (14.0)

127 (22.5)

64 (14.9)

0.79

Angina, no. (%)

36 (8.9)

107 (18.9)

53 (12.3)

0.17

Stroke, no. (%)

9 (2.2)

28 (5.0)

11 (2.6)

0.82

Cancer, no. (%)

38 (9.3)

73 (12.9)

45 (10.5)

0.63

  1. *BMI = Body Mass Index; HDL = high-density lipoprotein cholesterol; kg/m2 = kilograms/meters-squared; LDL = low-density lipoprotein cholesterol; mg/dL = milligrams/deciliter; No. = number; SD = standard deviation